Nephera, Ltd.: Series B $2.8M

Posted in I - Series B, Q - 3Q10, R - INTERNATIONAL, X - Device (Cardiology), X - Device (Renal)

Nephera (Israel) a development-stage medical device company focused on kidney function in CHF patients, closed a $2.8M Series B financing. Participants include Aurum Ventures, Evergreen Venture Partners and Trendlines Group.

Feb

2010

TVA Medical, Inc.: Series A $2.6M

Posted in I - Series A, Q - 1Q10, R - SOUTH WEST, X - Device (Renal), XX - TX

TVA Medical (Austin, TX) a development-stage medical device company focused on a minimally invasive approach for the treatment of end-stage renal disease, closed a $2.6M Series A financing. Participants include Santé Ventures.

Nov

2009

Quanta Fluid Solutions, Ltd.: Series A $14.3M

Posted in I - Series A, Q - 3Q09, R - INTERNATIONAL, X - Device (Renal)

Quanta Fluid Solutions (United Kingdom) a development-stage medical device company focused on haemodialysis systems for acute renal failure, has closed a $14.3M Series A financing. Participants include NBGI Ventures, Seroba Kernel Life Sciences, Wellington Partners Venture Capital and Brains-To-Ventures.

to top of page...